Differences in drug use and clinical application between Pazopanib (Viant) and Pazopanib

Pazopanib and pazopanib are actually the same drug, with only slightly different Chinese translations. Both refer to oral multi-target tyrosine kinase inhibitors developed by Pfizer, which mainly target VEGFR, PDGFR and c-Kit Signaling pathway. Due to differences in naming, "pazopanib" will be used in some literature or drug instructions, while "pazopanib" is also commonly called clinically, but the pharmacological ingredients and mechanism of action are completely the same.

In terms of pharmacological effects, pazopanib blocks the formation of tumor blood vessels by inhibiting the activity of tyrosine kinases related to angiogenesis, thereby limiting the blood supply and nutrient supply to the tumor. It also has a certain inhibitory effect on tumor cell proliferation. This mechanism of action applies to a variety of solid tumors, especially patients with blood vessel-dependent tumors such as advanced renal clear cell carcinoma and soft tissue sarcoma.

Since the two are essentially the same, there is no substantial difference in clinical application. Whether it is called pazopanib or pazopanib, its indications, administration methods, dosage regimens, efficacy and safety are the same. Patients do not need to worry about differences in drug efficacy when using it. The key is to choose regular drugs and appropriate dosages according to the doctor's prescription to ensure the safety and effectiveness of treatment.

It should be noted that differences in nomenclature may cause confusion among patients when accessing information or purchasing medications. Therefore, when using or consulting a doctor or pharmacist, you should clarify the generic name of the drug Pazopanib, and pay attention to the manufacturer and approval number of the drug to ensure that the source of the drug is regular and reliable. In general, pazopanib and pazopanib only differ in name, but are essentially the same, and their clinical applications and pharmacological mechanisms are consistent.

Reference link:https://www.drugs.com